참고문헌
- Ferlito A. The natural history of early vocal cord cancer. Acta Otolaryngol (Stockh). 1995;115:345-347. https://doi.org/10.3109/00016489509139326
- Groome PA, O'Sullivan B, Irish JC, Rothwell DM, Schulze K, Warde PR, et al. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States. Jpn J Clin Oncol. 2003;21:496-505. https://doi.org/10.1200/JCO.2003.10.106
- Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Management of T1-T2 Glottic carcinomas. Cancer. 2004;100:1786-1792. https://doi.org/10.1002/cncr.20181
- Jones AS, Fish B, Fenton JE, Husband DJ. The treatment of early laryngeal cancers (T1-T2 N0): Surgery or irradiation?. Head Neck. 2004;26:127-135. https://doi.org/10.1002/hed.10361
- Loughran S, Calder N, MacGregor FB, Carding P, MacKenzie K. Quality of life following endoscopic resection or radiotherapy for early glottic cancer. Clin Otolaryngol. 2005;30:42-47. https://doi.org/10.1111/j.1365-2273.2004.00919.x
- Lusinchi A, Dube P, Wibault P, Kunkler I, Luboinski B, Eschwege F. Radiation therapy in the treatment of early glottic carcinoma: The experience of Villejuif. Radiother Oncol. 1989;15:313-319. https://doi.org/10.1016/0167-8140(89)90076-5
- Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. Jpn J Clin Oncol. 2006;24:3693-3704. https://doi.org/10.1200/JCO.2006.07.4559
- Hirasawa N, Itoh Y, Ishihara S, Kubota S, Itoh J, Fujimoto Y, et al. Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: Retrospective analysis. Head Neck Oncol. 2010;2:20. https://doi.org/10.1186/1758-3284-2-20
- Furusaka T, Matuda H, Saito T, Katsura Y, Ikeda M. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone. Acta Otolaryngol (Stockh). 2012;132:546-551. https://doi.org/10.3109/00016489.2011.646008
- Arshad H, Jayaprakash V, Gupta V, Cohan DM, Ambujakshan D, Rigual NR, et al. Survival differences between organ preservation surgery and definitive radiotherapy in early supraglottic squamous cell carcinoma. Otolaryngol Head Neck Surg. 2014;150:237-244. https://doi.org/10.1177/0194599813512783
- Milas L, Mason KA, Liao Z, Ang KK. Chemoradiotherapy: Emerging treatment improvement strategies. Head Neck. 2003;25:152-167. https://doi.org/10.1002/hed.10232
- Nishimura G, Tsukuda M, Mikami Y, Matsuda H, Horiuchi C, Taguchi T, et al. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation. Anticancer Res. 2009;29:661-666.
- Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, et al. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys. 2006;64:995-1001. https://doi.org/10.1016/j.ijrobp.2005.10.003